Table 2 Ventricular volumes, function and masses of PRKAG2 mutation carriers compared to age, gender and body surface area standardized reference values
From: Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations
All | ||
|---|---|---|
(n = 6) | ||
Value | z-scorea | |
Left ventricle | ||
End-diastolic volume, ml | 163 (116–180) | |
End-diastolic volume index, ml/m2 | 90 (82–100) | 0.6 (-0.1–1.6) |
End-systolic volume, ml | 63 (38–72) | |
End-systolic volume index, ml/m2 | 34 (28–42) | 0.9 (-1.0–2.2) |
Stroke volume, ml | 99 (78–109) | |
Stroke volume index, ml/m2 | 57 (52–59) | 0.3 (-0.3–1.0) |
Cardiac output, l/min | 5.9 (4.8–8.2) | |
Cardiac output index, l/(minam2) | 3.5 (3.1–4.4) | |
LVEF, % | 62 (58–67) | −0.3 (-1.5–1.5) |
Mass, g | 137 (96–335) | |
Mass index, g/m2 | 78 (68–203) | 2.1 (-0.1–18.8) |
Right ventricle | ||
End-diastolic volume, ml | 167 (124–189) | |
End-diastolic volume index, ml/m2 | 95 (75–102) | 0.3 (-1.0–0.9) |
End-systolic volume, ml | 68 (38–83) | |
End-systolic volume index, ml/m2 | 39 (23–45) | 0.2 (-1.3–1.3) |
Stroke volume, ml | 99 (78–106) | |
Stroke volume index, ml/m2 | 56 (52–59) | 0.2 (-0.2–0.7) |
Cardiac output, l/min | 5.8 (4.9–8.2) | |
Cardiac output index, l/(minam2) | 3.5 (3.1–4.4) | |
RVEF, % | 59 (56–69) | 0.1 (-1.1–1.3) |